The internationally recognized genomics, cancer, stem cell, bioengineering, information technology, engineering, language, pharmaceutical and dental research underway at the University of Maryland produces a robust pipeline of more than 250 new advances each year.
Our discovery portfolio contains an exciting mix of vaccines, drug targets, robotics, therapeutics, devices, software tools and cutting-edge techniques in virtually every discipline. All promise to make a quantifiable impact on society.
UM Ventures' Technology Transfer offices license innovations developed by faculty, students and staff to industry partners from early stage start-ups to industry giants. Our services include evaluating, patenting, and licensing intellectual property.